What is it?
Identity
1Sulbutiamine is a synthetic disulfide derivative of thiamine designed to be more lipophilic than ordinary vitamin B1 salts. It should not be interpreted using nutritional thiamin evidence alone.
What human evidence shows
2Older studies in fatigue or asthenia populations provide limited, indirect evidence. They do not establish a dependable focus, memory, or wakefulness effect in healthy adults.
Names, aliases and forms
Potential effects and evidence map
Human evidence is sparse, older, and population-specific. Fatigue or asthenia findings should not be generalized to healthy-user cognition, and long-term safety, medication interactions, pregnancy, and lactation remain insufficiently characterized.
Fatigue and asthenia studies provide the main human signal, but results are condition-specific and mixed rather than a broad energy guarantee.
A small multiple-sclerosis fatigue study reported improvement, but the population and design limit generalization.
Routine memory or learning enhancement claims are not supported by strong human evidence.
Typical dosages and timing
This is study context from limited clinical populations, not a routine healthy-user recommendation or established cycle.
Timing & effect horizon
Acute onset, effect duration, and a reliable cycle have not been established. Study follow-up is not the same as same-day effect duration.
Safety, side effects and risk profile
Insomnia, restlessness, agitation, tremor, or late-day activation are plausible tolerability limits, especially when dose is increased or stacked with activating products.
Headache and dizziness are practical stop-and-reassess signals in sulbutiamine trials and reviews.
Nausea, diarrhea, abdominal discomfort, or appetite changes can occur and may set the upper practical dose limit.
The evidence base is limited, older in places, and focused on fatigue or asthenia populations rather than healthy nootropic users.
Short studies reported mostly mild adverse events, while long-term safety remains insufficiently characterized. Medication interactions, pregnancy, and lactation also lack adequate evidence.
Interactions and cautions
Interaction data are limited. Avoid assuming compatibility with medicines or using general B1 guidance for pregnancy or lactation.
Practical buying and quality notes
- Confirm sulbutiamine identity, amount per serving, independent purity testing, and total stimulant-like stack context. Do not compare it as ordinary thiamin.1
FAQ
Sulbutiamine versus vitamin B1
1Sulbutiamine is a synthetic lipophilic thiamine derivative rather than an essential B1 vitamer or ordinary thiamin salt. Its clinical evidence, studied amounts, and safety uncertainties must therefore be evaluated separately from nutritional thiamin.
References
- PubChem Compound Summary for Sulbutiamine. National Center for Biotechnology Information.
- Starling-Soares B, Carrera-Bastos P, Bettendorff L. Role of the Synthetic B1 Vitamin Sulbutiamine on Health. Journal of Nutrition and Metabolism. 2020.
- Sevim S, Kaleagasi H, Tasdelen B. Sulbutiamine shows promising results in reducing fatigue in patients with multiple sclerosis. Multiple Sclerosis and Related Disorders. 2017.
- Tiev KP, Cabane J, Imbert JC. clinical use of chronic postinfectious fatigue: randomized double-blind study of two doses of sulbutiamine (400-600 mg/day) versus placebo. La Revue de Medecine Interne. 1999.
- Shah SN; Sulbutiamine Study Group. Adjuvant role of vitamin B analogue (sulbutiamine) with anti-infective clinical use in infection associated asthenia. Journal of the Association of Physicians of India. 2003.
- Van Reeth O. Pharmacologic and therapeutic features of sulbutiamine. Drugs of Today. 1999.